Dyskinesias Clinical Trial
Official title:
Comparison of Open Chain Kinetic Exercises and Forward Head Posture Correction on Scapular Symmetry and Glenohumeral Disability in Office Workers With Type II Scapular Dyskinesia
Verified date | March 2022 |
Source | Riphah International University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The objective of this study is to compare the effect of open chain kinetic exercises and forward head posture correction on scapular symmetry and glenohumeral disability in office workers with type II scapular dyskinesis.
Status | Completed |
Enrollment | 42 |
Est. completion date | February 25, 2022 |
Est. primary completion date | February 15, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years to 40 Years |
Eligibility | Inclusion Criteria: - Both male and female office workers - In the age group of 20 to 40 years - With at least one year work experience - Individuals with Type II scapular dyskinesia (1-1.5 cm dif¬ference) - Individuals with forward head posture Exclusion Criteria: - Any Congenital abnormality - Neurological deficit - Received physiotherapy treatment in past three months |
Country | Name | City | State |
---|---|---|---|
Pakistan | Sarwat Anwar Medical Complex Hospital | Lahore | Punjab |
Lead Sponsor | Collaborator |
---|---|
Riphah International University |
Pakistan,
Castelein B, Cools A, Parlevliet T, Cagnie B. Are chronic neck pain, scapular dyskinesis and altered scapulothoracic muscle activity interrelated?: A case-control study with surface and fine-wire EMG. J Electromyogr Kinesiol. 2016 Dec;31:136-143. doi: 10.1016/j.jelekin.2016.10.008. Epub 2016 Oct 19. — View Citation
Christensen SW, Hirata RP, Graven-Nielsen T. The effect of experimental neck pain on pressure pain sensitivity and axioscapular motor control. J Pain. 2015 Apr;16(4):367-79. doi: 10.1016/j.jpain.2015.01.008. Epub 2015 Jan 29. — View Citation
Deng S, Chen K, Ma Y, Chen J, Huang M. The Influence of Test Positions on Clinical Assessment for Scapular Dyskinesis. PM R. 2017 Aug;9(8):761-766. doi: 10.1016/j.pmrj.2016.11.011. Epub 2016 Dec 1. — View Citation
Kibler WB, Sciascia A. The role of the scapula in preventing and treating shoulder instability. Knee Surg Sports Traumatol Arthrosc. 2016 Feb;24(2):390-7. doi: 10.1007/s00167-015-3736-z. Epub 2015 Aug 1. — View Citation
Lefèvre-Colau MM, Nguyen C, Palazzo C, Srour F, Paris G, Vuillemin V, Poiraudeau S, Roby-Brami A, Roren A. Kinematic patterns in normal and degenerative shoulders. Part II: Review of 3-D scapular kinematic patterns in patients with shoulder pain, and clinical implications. Ann Phys Rehabil Med. 2018 Jan;61(1):46-53. doi: 10.1016/j.rehab.2017.09.002. Epub 2017 Oct 5. Review. — View Citation
Lefèvre-Colau MM, Nguyen C, Palazzo C, Srour F, Paris G, Vuillemin V, Poiraudeau S, Roby-Brami A, Roren A. Recent advances in kinematics of the shoulder complex in healthy people. Ann Phys Rehabil Med. 2018 Jan;61(1):56-59. doi: 10.1016/j.rehab.2017.09.001. Epub 2017 Sep 28. — View Citation
Longo UG, Risi Ambrogioni L, Berton A, Candela V, Massaroni C, Carnevale A, Stelitano G, Schena E, Nazarian A, DeAngelis J, Denaro V. Erratum: Longo, U.G., et al. Scapular Dyskinesis: From Basic Science to Ultimate Treatment. International Journal of Environmental Research and Public Health 2020, 17(8), 2974. Int J Environ Res Public Health. 2020 May 27;17(11). pii: E3810. doi: 10.3390/ijerph17113810. — View Citation
Ozdemir F, Toy S. Evaluation of scapular dyskinesis and ergonomic risk level in office workers. Int J Occup Saf Ergon. 2021 Dec;27(4):1193-1198. doi: 10.1080/10803548.2020.1757307. Epub 2020 Jun 22. — View Citation
Panagiotopoulos AC, Crowther IM. Scapular Dyskinesia, the forgotten culprit of shoulder pain and how to rehabilitate. SICOT J. 2019;5:29. doi: 10.1051/sicotj/2019029. Epub 2019 Aug 20. — View Citation
Singla D, Veqar Z. Association Between Forward Head, Rounded Shoulders, and Increased Thoracic Kyphosis: A Review of the Literature. J Chiropr Med. 2017 Sep;16(3):220-229. doi: 10.1016/j.jcm.2017.03.004. Epub 2017 Sep 28. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | SPADI questionnaire | The Shoulder Pain and Disability Index (SPADI) was developed to measure current shoulder pain and disability in an outpatient setting. The SPADI contains 13 items that assess two domains; a 5-item subscale that measures pain and an 8-item subscale that measures disability. | 4 week | |
Primary | Lateral Scapular Slide Test (LSST) | Lateral Scapular Slide Test (LSST) will be used to evaluate the scapular dyskinesis. LSST asses scapular asymmetry under varying load positions. Measurements of scapular position are taken while scapular position with the arm abducted 0, 45, and 90 degrees in the coronal plane. Distance from the inferior angle of the scapula to the spinous process of the thoracic vertebra in the same horizontal plane was measured in all 3 position .If the distance is greater than 1.5 cm, it means LSST is positive | 4 weeks | |
Primary | Forward head posture measurement using Image J software | Forward head posture measurement will be assessed using a digitized , lateral view photograph(Sony 16.1 M pixels camera ) of the subject in his or her usual standing posture. The tragus of the subject's ear will be marked and a reflexive marker will be attached to the skin overlying C7 vertebrae. Once the photograph obtained we will use ImageJ software (20)to measure FHP quantified by the craniovertebral angle (The angle between the horizontal line passing through the C7 and a line extending from tragus of ear to C7). An angle less than 50-53 degrees may indicate FHP . Thereby, the smaller the CV angle, the greater the disability. | 4 weeks | |
Primary | Universal Goniometer | In Type 2 Scapula Dyskinesia, weakness of the serratus anterior results in reduction in both glenohumeral flexion and abduction .So these ranges will be measured before and after intervention in both groups with the help of goniometer. | 4 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00986414 -
Evaluation of the Efficacy and Safety of AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease
|
Phase 2 | |
Terminated |
NCT03270189 -
Effect of the Visual Information Change in Functional Dystonia
|
N/A | |
Completed |
NCT01474421 -
Safety and Efficacy of AQW051 in L-dopa Induced Dyskinesias in Patients With Parkinson's Disease
|
Phase 2 | |
Suspended |
NCT04912115 -
Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia
|
Phase 2 | |
Recruiting |
NCT05116813 -
Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based Therapy
|
Phase 2/Phase 3 | |
Completed |
NCT01385592 -
Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
|
Phase 2 | |
Completed |
NCT01491932 -
Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
|
Phase 2 | |
Completed |
NCT00086294 -
ACP-103 to Treat Parkinson's Disease
|
Phase 2 | |
Completed |
NCT00360568 -
Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects
|
Phase 3 | |
Recruiting |
NCT05317390 -
Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia
|
N/A | |
Completed |
NCT03956979 -
A Study in Parkinson's Disease in Patients With Moderate to Severe Dyskinesia
|
Phase 2 | |
Active, not recruiting |
NCT04453995 -
A Follow-up of the Influencing Factors of Dyskinesia in Patients With Parkinson's Disease
|
||
Not yet recruiting |
NCT05516875 -
Open-Label Extension Study of ASTORIA
|
Phase 2 | |
Terminated |
NCT02589340 -
Buspirone, in Combination With Amantadine, for the Treatment of Levodopa-induced Dyskinesia
|
Phase 1 | |
Completed |
NCT00076674 -
Levetiracetam Treatment of L-dopa Induced Dyskinesias
|
Phase 2 | |
Completed |
NCT00888186 -
Different Dyskinesias in Parkinson's Disease and Their Relation to Levodopa Pharmacokinetics
|
Phase 4 | |
Completed |
NCT00004576 -
Study of LY300164 for the Treatment of Parkinson's Disease
|
Phase 2 | |
Completed |
NCT00036296 -
Effects of Talampanel on Patients With Advanced Parkinson's Disease
|
Phase 1/Phase 2 | |
Completed |
NCT00363727 -
Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's
|
Phase 3 | |
Recruiting |
NCT04857359 -
Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy
|
Phase 2/Phase 3 |